Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardian Pharmacy Services (GRDN) Cash & Current Investments (2023 - 2025)

Guardian Pharmacy Services' Cash & Current Investments history spans 3 years, with the latest figure at $65.6 million for Q4 2025.

  • For Q4 2025, Cash & Current Investments rose 1308.13% year-over-year to $65.6 million; the TTM value through Dec 2025 reached $65.6 million, up 1308.13%, while the annual FY2025 figure was $65.6 million, 1308.13% up from the prior year.
  • Cash & Current Investments for Q4 2025 was $65.6 million at Guardian Pharmacy Services, up from $36.5 million in the prior quarter.
  • Across five years, Cash & Current Investments topped out at $65.6 million in Q4 2025 and bottomed at $752000.0 in Q4 2023.
  • The 3-year median for Cash & Current Investments is $18.8 million (2025), against an average of $25.4 million.
  • The largest YoY upside for Cash & Current Investments was 1308.13% in 2025 against a maximum downside of 1.97% in 2025.
  • A 3-year view of Cash & Current Investments shows it stood at $752000.0 in 2023, then skyrocketed by 519.68% to $4.7 million in 2024, then surged by 1308.13% to $65.6 million in 2025.
  • Per Business Quant, the three most recent readings for GRDN's Cash & Current Investments are $65.6 million (Q4 2025), $36.5 million (Q3 2025), and $18.8 million (Q2 2025).